Eurofins Biomnis is a provider of pathology diagnostic testing and offers reliable and timely services delivered by dedicated and fully trained staff. The company’s microbial testing range includes panels for sexually transmitted diseases (Atopobium, Chlamydia, Gardnerella, Mycoplasma, Neisseria gonorrhoeae, Trichomonas vaginalis, Ureaplasma urealyticum), bacterial and viral infectious diseases (HIV, hepatitis B and C viruses, human papillomavirus, CMV, EBV, parvovirus, , measles, influenza, pneumonia), specialised parasitology (toxocariasis, amoebiasis, ascariasis, filariasis) and emerging microbial diseases such as Zika and dengue fever. By ensuring that every test is performed to the highest standard every time, Eurofins Biomnis can help its customers make better informed healthcare decisions for patients. www.eurofins.co.uk/biomnis/our-services/medical-testing/microbiology/
Other News
Latest Issues
Epredia was established in July 2019 through the acquisition by PHC Group of the Anatomical Pathology division of Thermo Fisher Scientific. Our name has changed, however as a standalone business our mission remains the same: to improve lives by enhancing cancer diagnostics.
We are powered by the quality brands you know and trust, such as...
RSM / Path Soc 2026 Winter Meeting
The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE
20 - 21 January, 2026
BIVDA Regulatory Affairs Seminar
Grand Hotel, Birmingham
10 - 11 February, 2026
BDIAP Molecular Pathology Study Day
10 Union Street, London, SE1 1SZ
2 March, 2026
USCAP 115th Annual Meeting
Henry B. González Convention Center, San Antonio, Texas, USA
21 - 26 March, 2026
Microbiology Society Annual Conference 2026
ICC Belfast, Northern Ireland
13 - 16 April, 2026